Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Levered Free Cash Flow (FCF)

Aerie Pharmaceuticals Levered Free Cash Flow (FCF) Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Levered Free Cash Flow (FCF) from 2013 to 2020.
  • Aerie Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-5m a -261.50% increase of 13m year over year
  • Aerie Pharmaceuticals Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-74m a -24.04% increase of 18m year over year
  • Aerie Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2019 was $-104m a -4.53% increase of 5m from 2018
  • Aerie Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2018 was $-108m a 22.19% decrease of -24m from 2017
  • Aerie Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2017 was $-84m a 41.87% decrease of -35m from 2016
Other Cash Flow Metrics:
  • Aerie Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-43m a 39.56% decrease of -17m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Levered Free Cash Flow (FCF) Data

06/2020$-5m
03/2020$-25m
12/2019$-26m
09/2019$-18m
06/2019$-21m
03/2019$-38m
12/2018$-14m
09/2018$-29m
06/2018$-36m
03/2018$-28m

Annual AERI Levered Free Cash Flow (FCF) Data

2019$-104m
2018$-108m
2017$-84m
2016$-49m
2015$-31m
2014$-18m
2013$-9m
2012$-10m